BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19068252)

  • 1. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
    Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
    Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
    Refsum H; Wesenberg F; Ueland PM
    Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
    Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
    Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid changes in the excitatory amino acids concentration caused by the standard treatment of acute lymphoblastic leukaemia in children do not correlate with their later cognitive functioning.
    Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Krawczuk-Rybak M; Braszko JJ
    Neuropediatrics; 2009 Dec; 40(6):295-7. PubMed ID: 20446226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
    Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G
    Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No role for cerebrospinal fluid myelin basic protein levels in patients treated for childhood acute lymphoblastic leukemia.
    Diezi M; Garcia E; Weid Nv; Beck-Popovic M
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):393-7. PubMed ID: 19648787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of cerebral biopterin and biogenic amine metabolism in leukemic children receiving 5 g/m2 intravenous methotrexate.
    Millot F; Dhondt JL; Mazingue F; Mechinaud F; Ingrand P; Guilhot F
    Pediatr Res; 1995 Feb; 37(2):151-4. PubMed ID: 7537364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
    Li Y; Vijayanathan V; Gulinello M; Cole PD
    Pharmacol Biochem Behav; 2010 Jun; 95(4):428-33. PubMed ID: 20332001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
    Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
    Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folate.
    Valik D; Sterba J; Bajciova V; Demlova R
    Oncology; 2005; 69(3):269-72. PubMed ID: 16166815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
    Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
    Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
    Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
    Cole PD; Kamen BA
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
    Cohen IJ
    Pediatr Blood Cancer; 2009 Jul; 53(1):127; author reply 127-8. PubMed ID: 19340855
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid oxidative stress during chemotherapy of acute lymphoblastic leukemia in children.
    Protas PT; Muszynska-Roslan K; Holownia A; Krawczuk-Rybak M; Braszko JJ
    Pediatr Hematol Oncol; 2010 May; 27(4):306-13. PubMed ID: 20426521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
    Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
    Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.